Larimar Therapeutics, Inc. SEC filings LRMR
Larimar Therapeutics, Inc. has 696 filings in SEC EDGAR's recent list, going back to Aug 28, 2006. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 20, 2026 | Apr 17, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | May 19, 2026 |
| DEF 14A | Proxy statement | Apr 11, 2025 | Apr 9, 2025 |
| DEF 14A | Proxy statement | Apr 29, 2024 | May 29, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2024 | May 29, 2024 |
| DEF 14A | Proxy statement | Apr 11, 2023 | May 9, 2023 |
| DEF 14A | Proxy statement | Apr 12, 2022 | May 10, 2022 |
| DEF 14A | Proxy statement | Apr 14, 2021 | May 12, 2021 |
| DEFA14A | Additional proxy material | Aug 19, 2020 | — |
| DEF 14A | Proxy statement | Aug 19, 2020 | Sep 29, 2020 |
| DEFA14A | Additional proxy material | May 19, 2020 | — |
| DEFM14A | Filing | Apr 29, 2020 | — |
| DEFA14A | Additional proxy material | Mar 9, 2020 | — |
| PREM14A | Filing | Mar 6, 2020 | Mar 6, 2020 |
| DEFA14A | Additional proxy material | Feb 5, 2020 | — |
| DEFA14A | Additional proxy material | Jan 13, 2020 | — |
| DEFA14A | Additional proxy material | Dec 18, 2019 | — |
| DEFA14A | Additional proxy material | Dec 18, 2019 | — |
| DEF 14A | Proxy statement | Apr 26, 2019 | Jun 13, 2019 |
| DEF 14A | Proxy statement | Apr 18, 2018 | Jun 6, 2018 |
| DEF 14A | Proxy statement | Apr 28, 2017 | Jun 21, 2017 |
| DEF 14A | Proxy statement | May 4, 2016 | Jun 30, 2016 |
| DEF 14A | Proxy statement | Apr 30, 2015 | Jun 25, 2015 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LRMR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bala Cynwyd, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1374690
- Former names
- ZAFGEN, INC. (until May 19, 2020); ZAFGEN INC (until Nov 3, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.